Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Zeitschrift für Gerontologie und Geriatrie 3/2018

05.04.2018 | CME

Thromboembolieprophylaxe im Alter

verfasst von: Dr. Gabriele Röhrig, Prof. Dr. Gerald Kolb, AG Anämie der Deutschen Gesellschaft für Geriatrie (DGG)

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Einsatz von Antikoagulanzien beim älteren Menschen erfolgt im Spannungsfeld zwischen Blutungs- und Thromboembolierisiko. Neben dem Hauptrisikofaktor Alter beeinflussen Komorbiditäten (besonders Niereninsuffizienz) und Polymedikation die Blutungs- bzw. Thromboembolieneigung wesentlich. Doch Alter ist kein Ausschlusskriterium für Antikoagulanzien. Alter gilt als Hauptrisikofaktor für tiefe Venenthrombosen (TVT); auch Vorhofflimmern (VHF) gewinnt mit zunehmendem Lebensalter an Relevanz. Ältere Patienten mit VHF haben ein besonders hohes Risiko, einen Schlaganfall zu erleiden. Da das Blutungsrisiko im Vergleich zum Schlaganfallrisiko geringer ist, profitieren hochaltrige Patienten mit VHF besonders von einer Antikoagulationstherapie. Etablierte Diagnose-Scores helfen bei der Risikoeinschätzung. Dieser Beitrag gibt eine Übersicht über die Epidemiologie thrombembolischer Ereignisse im Alter sowie über aktuelle diagnostische und therapeutische Maßnahmen der Primär- und Sekundärprävention.
Literatur
2.
Zurück zum Zitat Harenberg J (2010) Antikoagulation bei älteren Patienten. Vasc Care 21:24–33 Harenberg J (2010) Antikoagulation bei älteren Patienten. Vasc Care 21:24–33
4.
Zurück zum Zitat Engbers MJ, van Hylckama Vlieg A, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8(10):2105–2112 CrossRefPubMed Engbers MJ, van Hylckama Vlieg A, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8(10):2105–2112 CrossRefPubMed
5.
Zurück zum Zitat Kohsytorz A, Kolb G (2001) Thromboembolierisiko und Gerinnungsaktivierung bei immobilisierten Pflegeheimbewohnern. Eur J Geriatr 3:146–152 Kohsytorz A, Kolb G (2001) Thromboembolierisiko und Gerinnungsaktivierung bei immobilisierten Pflegeheimbewohnern. Eur J Geriatr 3:146–152
6.
Zurück zum Zitat Kohsytorz A, Kolb G (2003) Thromboembolierisiko, Gerinnungsaktivierung – diagnostische, prognostische und prophylaktische Möglichkeiten im Alter. Eur J Geriatr 5:111–116 Kohsytorz A, Kolb G (2003) Thromboembolierisiko, Gerinnungsaktivierung – diagnostische, prognostische und prophylaktische Möglichkeiten im Alter. Eur J Geriatr 5:111–116
7.
Zurück zum Zitat Ohlmeier C, Mikolajczyk R, Haverkamp W et al (2013) Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace 15(10):1436–1444 CrossRefPubMed Ohlmeier C, Mikolajczyk R, Haverkamp W et al (2013) Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace 15(10):1436–1444 CrossRefPubMed
8.
Zurück zum Zitat Wilke T, Groth A, Mueller S et al (2013) Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 15(4):486–493 CrossRefPubMed Wilke T, Groth A, Mueller S et al (2013) Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 15(4):486–493 CrossRefPubMed
10.
Zurück zum Zitat Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375 CrossRefPubMed Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375 CrossRefPubMed
11.
Zurück zum Zitat Lin HJ, Wolf PA, Kelly-Hayes M et al (1996) Stroke severity in atrial fibrillation. The Framingham study. Stroke 27(10):1760–1764 CrossRefPubMed Lin HJ, Wolf PA, Kelly-Hayes M et al (1996) Stroke severity in atrial fibrillation. The Framingham study. Stroke 27(10):1760–1764 CrossRefPubMed
12.
Zurück zum Zitat Weberová D, Weber P, Kubesová H et al (2012) Occurrence of pulmonary embolism among 260 in-patients of acute geriatric department aged 65+ years in 2005–2010. Adv Gerontol 25(3):506–512 PubMed Weberová D, Weber P, Kubesová H et al (2012) Occurrence of pulmonary embolism among 260 in-patients of acute geriatric department aged 65+ years in 2005–2010. Adv Gerontol 25(3):506–512 PubMed
13.
Zurück zum Zitat Weberova D, Weber P, Meluzinova H et al (2014) Deceased elderly in-patients with pulmonary embolism. Bratisl Lek Listy 115(12):786–790 PubMed Weberova D, Weber P, Meluzinova H et al (2014) Deceased elderly in-patients with pulmonary embolism. Bratisl Lek Listy 115(12):786–790 PubMed
14.
Zurück zum Zitat Righini M, Le Gal G, Perrier A et al (2005) The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J Am Geriatr Soc 53(6):1039–1045 CrossRefPubMed Righini M, Le Gal G, Perrier A et al (2005) The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J Am Geriatr Soc 53(6):1039–1045 CrossRefPubMed
15.
Zurück zum Zitat Franceschi C, Bonafè M, Valensin S et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254 CrossRefPubMed Franceschi C, Bonafè M, Valensin S et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254 CrossRefPubMed
16.
Zurück zum Zitat Schouten HJ, Geersing GJ, Koek HL et al (2013) Diagnostic accuracy of conventional or age adjusted D‑dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ 346:f2492 CrossRefPubMedPubMedCentral Schouten HJ, Geersing GJ, Koek HL et al (2013) Diagnostic accuracy of conventional or age adjusted D‑dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ 346:f2492 CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wells PS, Hirsh J, Anderson DR et al (1995) Accuracy of clinical assessment of deep-vein thrombosis. Lancet 345(8961):1326–1330 CrossRefPubMed Wells PS, Hirsh J, Anderson DR et al (1995) Accuracy of clinical assessment of deep-vein thrombosis. Lancet 345(8961):1326–1330 CrossRefPubMed
19.
Zurück zum Zitat Goodacre S, Sutton AJ, Sampson FC (2005) Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 143(2):129–139 CrossRefPubMed Goodacre S, Sutton AJ, Sampson FC (2005) Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 143(2):129–139 CrossRefPubMed
20.
Zurück zum Zitat Sampson FC, Goodacre SW, Thomas SM et al (2007) The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 17(1):175–181 CrossRefPubMed Sampson FC, Goodacre SW, Thomas SM et al (2007) The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 17(1):175–181 CrossRefPubMed
21.
Zurück zum Zitat Thomas SM, Goodacre SW, Sampson FC et al (2008) Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol 63(3):299–304 CrossRefPubMed Thomas SM, Goodacre SW, Sampson FC et al (2008) Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol 63(3):299–304 CrossRefPubMed
22.
Zurück zum Zitat Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), Konstantinides SV, Torbicki A, Agnelli G et al (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–69, 3069a–3069k CrossRef Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), Konstantinides SV, Torbicki A, Agnelli G et al (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–69, 3069a–3069k CrossRef
23.
Zurück zum Zitat Wells PS, Ginsberg JS, Anderson DR et al (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129(12):997–1005 CrossRefPubMed Wells PS, Ginsberg JS, Anderson DR et al (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129(12):997–1005 CrossRefPubMed
24.
Zurück zum Zitat Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429 CrossRefPubMed Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429 CrossRefPubMed
25.
Zurück zum Zitat Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962 CrossRefPubMed Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962 CrossRefPubMed
27.
Zurück zum Zitat Lee AY (2005) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 128(3):291–302 CrossRefPubMed Lee AY (2005) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 128(3):291–302 CrossRefPubMed
28.
Zurück zum Zitat Carrier M, Le Gal G, Wells PS et al (2008) Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149(5):323–333 CrossRefPubMed Carrier M, Le Gal G, Wells PS et al (2008) Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149(5):323–333 CrossRefPubMed
29.
Zurück zum Zitat SOMIT Investigators Group, Piccioli A, Lensing AW, Prins MH et al (2004) Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2(6):884–889 CrossRef SOMIT Investigators Group, Piccioli A, Lensing AW, Prins MH et al (2004) Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2(6):884–889 CrossRef
30.
Zurück zum Zitat Monreal M, Lensing AW, Prins MH et al (2004) Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2(6):876–881 CrossRefPubMed Monreal M, Lensing AW, Prins MH et al (2004) Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2(6):876–881 CrossRefPubMed
31.
Zurück zum Zitat DERECUS Investigators Group, Prandoni P, Lensing AW, Bernardi E et al (2002) The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 88(3):402–406 DERECUS Investigators Group, Prandoni P, Lensing AW, Bernardi E et al (2002) The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 88(3):402–406
32.
Zurück zum Zitat Le Gal G, Kovacs MJ, Carrier M et al (2009) Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost 7(5):752–759 CrossRefPubMed Le Gal G, Kovacs MJ, Carrier M et al (2009) Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost 7(5):752–759 CrossRefPubMed
33.
Zurück zum Zitat Adam SS, Key NS, Greenberg CS (2009) D‑dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887 CrossRefPubMed Adam SS, Key NS, Greenberg CS (2009) D‑dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887 CrossRefPubMed
35.
Zurück zum Zitat Prisco D, Grifoni E (2009) The role of D‑dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost 35(1):50–59 CrossRefPubMed Prisco D, Grifoni E (2009) The role of D‑dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost 35(1):50–59 CrossRefPubMed
36.
Zurück zum Zitat Galster H, Kolb G, al Kohsytorz Aet (2000) The pre-, peri- and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 100(5):381–388 CrossRefPubMed Galster H, Kolb G, al Kohsytorz Aet (2000) The pre-, peri- and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 100(5):381–388 CrossRefPubMed
37.
Zurück zum Zitat Kolb G, Bodamer I, Galster H et al (2003) Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients. Thromb Haemost 90:1100–1105 PubMed Kolb G, Bodamer I, Galster H et al (2003) Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients. Thromb Haemost 90:1100–1105 PubMed
39.
Zurück zum Zitat Mant J, Hobbs FD, Fletcher K et al (2007) BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493–503 CrossRefPubMed Mant J, Hobbs FD, Fletcher K et al (2007) BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493–503 CrossRefPubMed
40.
Zurück zum Zitat Dodson JA, Petrone A, Gagnon DR et al (2016) Incidence and determinants of traumatic Intracranial bleeding among older veterans receiving warfarin for atrial fibrillation. JAMA Cardiol 1(1):65–72 CrossRefPubMedPubMedCentral Dodson JA, Petrone A, Gagnon DR et al (2016) Incidence and determinants of traumatic Intracranial bleeding among older veterans receiving warfarin for atrial fibrillation. JAMA Cardiol 1(1):65–72 CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Bahrmann P, Harms F, Schambeck CM et al (2016) New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients. Z Gerontol Geriatr 49(5):460–461 CrossRefPubMed Bahrmann P, Harms F, Schambeck CM et al (2016) New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients. Z Gerontol Geriatr 49(5):460–461 CrossRefPubMed
42.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272 CrossRefPubMed Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272 CrossRefPubMed
44.
Zurück zum Zitat Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1‑year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100 CrossRefPubMed Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1‑year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100 CrossRefPubMed
45.
Zurück zum Zitat Bahrmann P, Wehling M, Ropers D et al (2015) Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel. Drug Res (stuttg) 65(10):505–514 Bahrmann P, Wehling M, Ropers D et al (2015) Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel. Drug Res (stuttg) 65(10):505–514
46.
Zurück zum Zitat Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2(5):200–215 CrossRefPubMed Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2(5):200–215 CrossRefPubMed
47.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) „Mini-mental state“. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198 CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) „Mini-mental state“. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198 CrossRefPubMed
48.
Zurück zum Zitat Kalbe E, Kessler J, Calabrese P et al (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19(2):136–143 CrossRefPubMed Kalbe E, Kessler J, Calabrese P et al (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19(2):136–143 CrossRefPubMed
49.
Zurück zum Zitat Mahoney FI, Barthel DW (1965) Functional evaluation : the Barthel index. Md State Med J 14:61–65 PubMed Mahoney FI, Barthel DW (1965) Functional evaluation : the Barthel index. Md State Med J 14:61–65 PubMed
50.
Zurück zum Zitat Nikolaus T, Bach M, Specht-Leible N et al (1995) The Timed Test of Money Counting: a short physical performance test for manual dexterity and cognitive capacity. Age Ageing 24(3):257–258 CrossRefPubMed Nikolaus T, Bach M, Specht-Leible N et al (1995) The Timed Test of Money Counting: a short physical performance test for manual dexterity and cognitive capacity. Age Ageing 24(3):257–258 CrossRefPubMed
51.
Zurück zum Zitat Podsiadlo D, Richardson S (1991) The timed „Up & Go“: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148 CrossRefPubMed Podsiadlo D, Richardson S (1991) The timed „Up & Go“: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148 CrossRefPubMed
52.
Zurück zum Zitat Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48(2):133–143 CrossRefPubMed Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48(2):133–143 CrossRefPubMed
53.
Zurück zum Zitat Coordinating Committee, De Caterina R, Husted S, Wallentin L et al (2012) New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 59(16):1413–1425 CrossRef Coordinating Committee, De Caterina R, Husted S, Wallentin L et al (2012) New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 59(16):1413–1425 CrossRef
54.
Zurück zum Zitat Kunisch R (2012) Medizinsoftware für die Kitteltasche: Medikamenten-Apps. Dtsch Arztebl 109(9):A-440 Kunisch R (2012) Medizinsoftware für die Kitteltasche: Medikamenten-Apps. Dtsch Arztebl 109(9):A-440
55.
Zurück zum Zitat Friberg L, Oldgren J (2017) Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. Open Heart 4(2):e682 CrossRefPubMedPubMedCentral Friberg L, Oldgren J (2017) Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. Open Heart 4(2):e682 CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Hickey M, Gatien M, Taljaard M et al (2013) Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 128:360–364 CrossRefPubMed Hickey M, Gatien M, Taljaard M et al (2013) Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 128:360–364 CrossRefPubMed
Metadaten
Titel
Thromboembolieprophylaxe im Alter
verfasst von
Dr. Gabriele Röhrig
Prof. Dr. Gerald Kolb
AG Anämie der Deutschen Gesellschaft für Geriatrie (DGG)
Publikationsdatum
05.04.2018
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 3/2018
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-018-1384-x

Weitere Artikel der Ausgabe 3/2018

Zeitschrift für Gerontologie und Geriatrie 3/2018 Zur Ausgabe

Mitteilungen der DGGG

Mitteilungen der DGGG

Journal Club

Journal Club